Previous 10 | Next 10 |
home / stock / jazz / jazz articles
"Tell me and I forget, teach me and I may remember, involve me and I learn." Benjamin Franklin When it comes to the cannabis industry, one of the ...
Redx to receive $10 million upfront; potential for up to $870 million in development, regulatory and sales milestone payments in addition to royal...
An Australian, vertically integrated plant-based medicine company, Cannatrek, will collaborate with a Japanese University to empower research on m...
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced top-line results from the Phase 2 trial of JZP150, an investigational small molecule selecti...
Japan’s Parliament passed a bill Wednesday legalizing medical products derived from cannabis. The news comes some three weeks after the ...
Around 8% of Australians are using medical marijuana either occasionally or regularly, according to a recent survey of 1,000 participants cond...
Medical Cannabis-Based Epidiolex Advances Through Japan's Legislature Earlier this week, Japanese policymakers gave the green light to a m...
Researchers with the Food and Drug Administration (FDA) reported Wednesday on the agency’s 50 years of experience with marijuana research. In...
Althea Group Holdings Limited (ASX: AGH), an Australian manufacturer of cannabis-based medicines and recreational cannabis products confi...
News, Short Squeeze, Breakout and More Instantly...
Jazz Pharmaceuticals plc Company Name:
JAZZ Stock Symbol:
NASDAQ Market:
Jazz Pharmaceuticals plc Website:
Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting PR Newswire Ms. Hamill brings extensive experience and proven leadership focused on commercial growth and shareholder value DUBLIN , July 25, 20...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / Jazz Pharmaceuticals Originally published by Jazz Pharmaceuticals In celebration of Pride Month , we were joined by Celia Sandhya Daniels (she/they) who led an insightful discussion aimed at educating, raising awareness and calling for unders...
Jazz Pharmaceuticals Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for the 2.000% Exchangeable Senior Notes due 2026 PR Newswire DUBLIN , July 22, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ...